FAKTOR-ZERTIFIKAT - TANDEM DIABETES CARE Stock

Certificat

DE000JK5DSR5

Market Closed - Bid/Ask 12:53:18 2024-07-11 pm EDT After market 02:52:50 pm
6.3 EUR +14.75% Intraday chart for FAKTOR-ZERTIFIKAT - TANDEM DIABETES CARE 6.08 -3.49%
Current month+43.72%
1 month-72.03%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-11 6.3 +14.75%
24-07-10 5.49 +29.18%
24-07-09 4.25 +10.68%
24-07-08 3.84 +26.32%
24-07-05 3.04 +8.19%

Delayed Quote Börse Stuttgart

Last update July 11, 2024 at 12:53 pm EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying TANDEM DIABETES CARE, INC.
Issuer J.P. Morgan
WKN JK5DSR
ISINDE000JK5DSR5
Date issued 2024-03-22
Strike 37.99 $
Maturity Unlimited
Parity 1.23 : 1
Emission price 10.15
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 46.08
Lowest since issue 2.47
Spread 0.5
Spread %7.79%

Company Profile

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Sector
-
More about the company

Ratings for Tandem Diabetes Care, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Tandem Diabetes Care, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
44.31 USD
Average target price
49.93 USD
Spread / Average Target
+12.69%
Consensus